SoliPharma excels in solid-state research and complex formulation. As a leading CDMO, we provide comprehensive development and manufacturing services to global clients. By harnessing our expertise, we maximize the potential of your innovative drug molecules.
SoliPharma has been a trusted CDMO partner for over 15 years, serving 800+ global clients. We've successfully completed pre-formulation and formulation for 2000+ compounds at different clinical stages and annually generated 200K+ analytical testing reports, empowering our clients to navigate IND/NDA/ANDA submissions with confidence to both China NMPA and US FDA.
● Form Screening and Crystallization Development
● Control of Solid Form in Finished Products
● Crystal Growth of Polymeric Additives
● Formulation Development for Poorly Soluble Drugs
● Formulation Development for Poorly Permeable Drugs
● Formulation Development for Reactive Molecules
● Development of New Permeation Enhancer
● Follicular Target Delivery
● Extended Release for Topicals
● Semi-Solids
● Fixed Dose Combination
● Formulation with Complex APIs
Form Screening & Selection , Crystallization Process Development , Form Control in Drug Product
Innovative Technologies for Enhanced Penetration , Follicular Target Drug Delivery , Extended Release of Topical and Transdermal Delivery
FIH Development Accelerator
Regulatory Filing to Multiple Authority Agencies
Complex formulation including:Topical (gel, cream, ointment, emulgel, solution etc.)
Multiple Dosage Forms
Flexible batch size
Pass NMPA & FDA GMP Inspection
Comprehensive Analytical Testing , Method Development and Validation , Conforms to GMP/CNAS/UL
● Our Follicular Target Drug Delivery Project is sponsored by Provincial R&D Fund for Major Projects – Pioneer and Leading Goose R&D Program of Zhejiang 2023
● Our team’s state-of-the-art material characterization capabilities deliver reliable results and accelerate drug development.
● Our GMP facility features multiple production lines and versatile equipment size to accommodate diverse batch demands for clinical or commercial supply.
● We have successfully passed GMP inspections from prestigious organizations including USFDA, NMPA, and UL, and we have also obtained CNAS accreditation.
● We have provided more than 15 years of excellent service to the pharmaceutical industries.
● Our in-house R&D experience database features a diverse collection of over 200 formulation protocols and more than 20 animal models.
● Our services have extended to over 800 global clients, and have conducted pre-formulation and formulation development for more than 2,000 molecules across different clinical phases.
